Improving speech in Parkinson's patients with deep brain stimulation
Official title: REducing SPEECH-related Side-effects of Deep Brain Stimulation in Parkinson's Disease Via Automated Speech Analysis
Run by Insel Gruppe AG, University Hospital Bern · NCT05182892 · Data updated 2026-11-12
This study is testing if deep brain stimulation can improve speech quality in people with Parkinson's disease while also looking at how medication affects their speech.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 45 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 2 sites (Prague and 1 other locations) |
| Status | Recruiting |
| Started | December 13, 2021 |
| Main results expected | November 30, 2025 |
| Study ends | February 28, 2026 |
| Registry record updated | April 9, 2025 |
| Trial ID | NCT05182892 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with idiopathic Parkinson's disease who have undergone bilateral deep brain stimulation and experience speech difficulties related to the treatment.
✕Probably not a fit
Patients whose speech disorders are caused by conditions other than Parkinson's disease or deep brain stimulation, such as stroke or myasthenia, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance speech quality in patients with Parkinson's disease who experience speech disorders due to deep brain stimulation (DBS) of the subthalamic nucleus. By utilizing automated acoustic analysis, the researchers will identify specific speech variables that can help differentiate between speech improvements and side effects caused by DBS. The study will assess patients in both medicated and unmedicated states to gather comprehensive data on their speech patterns. The ultimate goal is to reduce the incidence of dysarthria associated with DBS while improving overall communication abilities.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life for Parkinson's patients by enhancing their speech capabilities.
How similar studies have gone: While there have been studies on speech disorders in Parkinson's disease, the specific use of automated acoustic analysis in conjunction with DBS is a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Idiopathic Parkinson-Syndrome according to the Movement Disorders Society Criteria * Treatment with bilateral deep brain stimulation in the subthalamic nucleus (for parts 1, 2 and 3) * Time since DBS-STN operation ≥ 3 month (for parts 1, 2 and 3) * Able to give informed consent as documented by signature * Fluent in Swiss-German or German * STN-DBS-induced dysarthria. In an operational definition, all PD-patients who reported -worsening of speech time-locked to STN-DBS implantation or patients with dysarthria on chronic stimulation improving with reduction of stimulation amplitudes in the context of postoperative routine follow up will be defined as having STN-DBS-induced dysarthria Exclusion Criteria: * Dysarthria caused in addition by a condition other than PD or DBS (e.g. stroke, myasthenia) * Clinical diagnosis of aphasia * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders and dementia. A Montreal Cognitive Assesment (MoCa) will be performed and patients with ≤ 20 of 30 points will be excluded * Change of parkinsonian medication in the last four weeks prior to inclusion in part 1 and 3 * Change of STN-DBS parameters in the last four weeks prior to inclusion (for parts 1 and 3) * Depression with acute suicidal ideation * Pregnant women
Where it's running
-
University Hospital Inselspital, Berne
Bern, Switzerland Recruiting -
Czech Technical University Prague
Prague, Czechia Active not recruiting
Study contacts
- Principal investigator: Paul Krack, Prof. — Insel Gruppe AG, University Hospital Bern
- Study coordinator: Paul Krack, Prof.
- Email: paul.krack@insel.ch
- Phone: 31 632 21 68
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.